The harmful effect of indoxyl sulfate on neovascularization in chronic kidney disease.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 26880447.
- Also identified by DOI 10.1016/j.kint.2015.12.030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with chronic kidney disease display an impairment of neovascularization in ischemic tissues. Studies have suggested the involvement of the uremic toxin indoxyl sulfate by demonstrating that indoxyl sulfate affects endothelial progenitor cells. However, few data are available on the effects of indoxyl sulfate on neovascularization and on the mechanisms involved. The article by Hung et al. shows that indoxyl sulfate suppresses neovascularization in uremic mice by impairing endothelial progenitor cell function via the inhibition of hypoxia-induced hypoxia-inducible factor/interleukin-10/vascular endothelial growth factor signaling.
Medical subject headings
- Indican
- Vascular Endothelial Growth Factor A